90 results on '"Mikhaĭlova AA"'
Search Results
2. [Fluorescently labeled differentiating myelopeptide-4: specific binding to and penetration into target cells]
3. [Extracorporeal shock wave therapy in athletes with degenerative and dystrophic disorders of locomotory system].
4. [Increased functional resources in athletes of cyclic sports].
5. [Synthesis and properties of the myelopeptides with differentiating activity].
6. [Functional activity of bone marrow-derived peptides (myelopeptides)].
7. [Myelopeptide MP-5 and fluorescent derivatives: synthesis and biological activity].
8. [Enhancement of measles-mumps divaccine using myelopeptide 2 in experiment].
9. [Fluorescently labeled differentiating myelopeptide-4: specific binding to and penetration into target cells].
10. [Effect of myelopeptide 2 on the immunization of guinea pigs with live measles vaccine].
11. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
12. [Myelopeptide-3 activates macrophage function].
13. [Myelopeptides as a new group of regulatory peptides].
14. [Myelopeptide-3--a bone marrow mediator, stimulating macrophage phagocytic activity].
15. [Myelopeptide-4--a new endogenous factor for differentiation of myeloid cells].
16. [Reason for the damping effect of tumor cells on human T-lymphocytes].
17. [The immunocorrective activity of myelopeptide-1 and myelopeptide-2 in cyclophosphane-treated mice].
18. [A myelopeptide (bivalfor), possessing antitumor activity].
19. [A myelopeptide, ameliorating the toxic effect of tumor cells on the functional activity of T-lymphocytes].
20. [Immunoregulatory properties of myelopeptide-1].
21. [Isolation and structure determination of biologically active peptides from the bone marrow].
22. [The effect of a glycoprotein from bone marrow (an amplifying protein) on the functional activity of growth factors].
23. [The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].
24. [Changes in the phagocytic activity of macrophages under the action of different doses of antibiotics].
25. [Immunocorrecting properties of antibiotics in secondary immunodeficiency].
26. [Bone marrow high molecular weight glycoprotein, intensifying the activity of granulocyte-macrophage colony-stimulating factor].
27. [Structure of two myelopeptides affecting pain sensitivity].
28. [Myelopeptides inhibit development of hereditary macrocytic anemia in W/Wv mice].
29. [Reflexotherapy of neurotic patients with depressive-hypochondriacal manifestations].
30. [Reaction of the blood system to the administration of a bone marrow mediator stimulating antibody production].
31. [Effect of a bone marrow stimulator of antibody producers on virus-specific antibody formation in animals infected with flaviviruses].
32. [Initiation of antibody synthesis in a "silent" population of antibody producers by the bone marrow mediator--stimulator of antibody producers (SAP)].
33. [Economic aspects of producing standard anti-ABO sera].
34. [Rhesus serological status of hemophilia patients].
35. [Serotoninergic and catecholaminergic indices in patients with neurotic and depressive disorders and changes in them as a result of reflexotherapy].
36. [Use of amniotic fluid in the production of a universal anti-Rhesus reagent].
37. [The immune system: hormones and mediators].
38. [Polyfunctionality of bone marrow peptides].
39. [Reflexotherapy of asthenic conditions in neuroses].
40. [Endorphin-like properties of a bone-marrow stimulant of antibody producers].
41. [The analgesic effect of various fractions of the supernatant of a bone marrow cell culture in pathologic pain].
42. [Prevention of immunization of CCdee genotype donors with erythrocytes of ccDee genotype].
43. [Correction of immune response by myelopeptides in MRL/Mp-lpr/lpr mice with congenital autoimmune disorders].
44. [Rapid method of serological selection of donor blood for isosensitized recipients].
45. [Role of T-suppressors in stimulating antibody formation at the level of mature antibody producers].
46. [Excretion of catecholamines and their precursor DOPA in patients with meningococcal infection].
47. [Influence of radiation and of the quantitative correlation of interacting cells on the stimulating effect of immunoglobulin synthesis in a mixed culture].
48. [Regulatory mediators of the bone marrow--myelopeptides].
49. [Effect of myelopeptides on the synthesis of DNA and total protein in the cells of the lymphoid organs in the mouse].
50. [Role of discrete cell populations in the effect of stimulation of antibody formation in a mixed culture of immune lymph node and intact bone marrow cells].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.